Company Profile
- Stock Code
- ROIV
- ISIN Code
- BMG762791017
- Currency
- US Dollar (USD)
- IPO Date
- 2021-10-01

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activa...